CNS neuroscience & therapeutics

How the p62/Nrf2/Keap1 Pathway May Be Involved in Brain Problems Caused by Lead Exposure

Updated

Abstract

Lead (Pb) exposure may trigger excessive production of reactive oxygen species (ROS) and disrupt neuronal function.

  • Pb exposure is associated with increased levels of in neurons.
  • The protein P62 interacts with the Nrf2/Keap1 pathway, disrupting normal autophagy processes.
  • This disruption leads to the accumulation of Tau protein, which is linked to Alzheimer's disease.
  • Treatment with antioxidants and autophagy activators may reduce the harmful effects of Pb exposure on neurons.

Simplified

Key numbers

2 mg/kg
Increase in Levels
(CHO) administered to rats via intraperitoneal injections.
50 μM
Decrease in Expression
Concentration of leading to observable cellular damage in .

Key figures

FIGURE 1
Control vs -exposed rats: lead levels, learning and memory, and hippocampal tissue changes
Highlights higher lead accumulation and impaired memory with visible hippocampal damage in Pb-exposed rats
CNS-31-e70566-g003
  • Panel A
    Blood and Pb levels; Pb group shows significantly higher Pb concentrations than control
  • Panel B
    test results; Pb group has longer escape latency on days 4 and 5 and fewer probe times than control
  • Panel C
    of hippocampus and regions; Pb group shows visible cellular damage and structural changes indicated by arrows
  • Panel D
    of hippocampus CA3 and DG regions; Pb group appears to have reduced neuronal density compared to control
FIGURE 2
exposure vs oxidative damage and cell changes in
Highlights increased and reduced antioxidant activity in Pb-exposed neuronal cells.
CNS-31-e70566-g009
  • Panel A
    Cell viability decreases as Pb concentration increases from 0 to 200 μmol/L, with significant reductions at 25 μmol/L and above.
  • Panel B
    Phenotypic changes in SH-SY5Y cells stained for (red) and nuclei (blue) show altered cell morphology at increasing Pb concentrations (25, 50, 100 μmol/L) compared to control.
  • Panel C
    levels detected by (green) visibly increase with higher Pb concentrations, with the highest intensity at 200 μmol/L and in the positive control (Rosup).
  • Panel D
    activity measured in SH-SY5Y cells decreases with Pb exposure, with a statistically significant reduction at 100 μmol/L compared to control.
FIGURE 3
, , and protein expression in -exposed cells and rat
Highlights reduced antioxidant protein levels and increased Keap1 in Pb-exposed cells and rat brain tissue
CNS-31-e70566-g006
  • Panel A
    images of Nrf2 (green) and nuclei (, blue) in exposed to 0, 25, 50, and 100 µM Pb; Nrf2 signal visibly decreases with higher Pb concentrations
  • Panel B
    Western blots and quantification of Nrf2, Keap1, and HO-1 proteins in SH-SY5Y cells treated with 0, 25, 50, and 100 µM Pb; Nrf2 and HO-1 protein levels decrease while Keap1 protein levels increase with higher Pb doses
  • Panel C
    Western blots and quantification of Nrf2, Keap1, and HO-1 proteins in hippocampus tissue from control and Pb-exposed rats; Pb exposure reduces Nrf2 and HO-1 levels and increases Keap1 levels
FIGURE 4
-exposed cells and rats: protein levels related to and in neurons
Highlights increased and protein levels in Pb-exposed neurons and rat .
CNS-31-e70566-g005
  • Panel A
    Western blot of and P62 protein levels in exposed to 0, 25, 50, and 100 μM Pb with quantification; no significant changes in LC3II/I ratio, P62 appears slightly increased at 100 μM Pb.
  • Panel B
    images showing LC3 protein (red) and nuclei (blue) in SH-SY5Y cells under control, Pb exposure (25, 50, 100 μM), and Rapamycin (RAPA) treatment; LC3 signal appears visibly brighter in RAPA-treated cells.
  • Panel C
    Western blot of phosphorylated Tau (P-Tau) and total Tau in SH-SY5Y cells exposed to Pb with quantification; P-Tau levels increase significantly at 100 μM Pb.
  • Panel D
    Western blot of LC3 and P62 proteins in hippocampus of control and Pb-exposed rats with quantification; P62 protein level is significantly higher in Pb-exposed rats.
  • Panel E
    Western blot of phosphorylated Tau (P-Tau) and total Tau in hippocampus of control and Pb-exposed rats with quantification; P-Tau level is significantly higher in Pb-exposed rats.
FIGURE 5
, , and protein levels and overlap in of control vs -exposed rats
Highlights altered Nrf2, P62, and Keap1 protein patterns in Pb-exposed hippocampus versus controls
CNS-31-e70566-g001
  • Panels leftmost
    Low-magnification views of hippocampus sections stained with (blue) showing overall tissue structure in control and Pb-exposed rats
  • Panels second from left
    Higher magnification of DAPI-stained nuclei in control and Pb-exposed hippocampus
  • Panels middle
    P62 protein (red) expression in hippocampus of control and Pb-exposed rats
  • Panels second from right
    Nrf2 protein (green) expression in hippocampus of control and Pb-exposed rats
  • Panels rightmost
    Keap1 protein (purple) expression and merged image showing co-localization of DAPI, Nrf2, P62, and Keap1 in control and Pb-exposed hippocampus
1 / 5

Full Text

What this is

  • Lead (Pb) exposure contributes to neurodegenerative diseases by inducing and disrupting cellular pathways.
  • This study investigates the P62/Nrf2/Keap1 signaling pathway's role in Pb-induced neuronal dysfunction.
  • Findings indicate that Pb exposure leads to oxidative damage and impaired , highlighting potential therapeutic targets.

Essence

  • Pb exposure disrupts the P62/Nrf2/Keap1 signaling pathway, leading to and neurodegeneration. Treatments like antioxidants and Nrf2 activators may mitigate these effects.

Key takeaways

  • Pb exposure triggers excessive reactive oxygen species (ROS) production, leading to neuronal oxidative damage. This is characterized by increased Keap1 expression and decreased Nrf2 levels.
  • The protein P62 accumulates due to Pb exposure, disrupting normal autophagic processes and leading to Tau protein accumulation, which is associated with Alzheimer's disease.
  • Antioxidants like N-acetylcysteine and Nrf2 activators can ameliorate Pb-induced oxidative damage, suggesting potential therapeutic strategies for Pb neurotoxicity.

Caveats

  • The study primarily uses animal models, which may not fully replicate human responses to Pb exposure. Further research is needed to validate findings in human populations.
  • While treatments showed promise in mitigating Pb-induced damage, their efficacy in clinical settings remains to be established through rigorous trials.

Definitions

  • oxidative stress: An imbalance between the production of reactive oxygen species and the body's ability to detoxify them, leading to cellular damage.
  • autophagy: A cellular process that degrades and recycles damaged organelles and proteins to maintain cellular health.

Simplified

Funding

Competing interests

The authors declare no conflicts of interest.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free